Fresenius Medical Care (NYSE:FMS; ETR:FRE) last week recalled two sets of its bloodlines due to potentially deadly leaks in the tubes. Germany-based Fresenius said that two sets of its 4008 bloodlines (AV-Set B-R F00001124 and AV-Set SRB-R F00000257) containing a total of 25 batches experienced tube rupture that led to blood leakage. A dialysis machine cannot […]
Fresenius invests in BioIntelliSense
Fresenius Medical Care (NYSE:FMS; ETR:FRE) today announced an investment in BioIntelliSense for an undisclosed amount. Denver-based BioIntelliSense is developing a medical-grade data services platform for continuous remote health monitoring, predictive analytics and algorithmic clinical insights. Through the agreement, Fresenius will use the advanced analytics and artificial intelligence to develop medical wearables for clinical pathways that allow […]
Fresenius to expand kidney research
Fresenius Medical Care (NYSE:FMS; ETR:FRE) said this week that it is expanding its clinical research activities. Frenova Renal Research, previously a Fresenius Medical Care North America subsidiary, will now offer its services worldwide and will be integrated into a new global medical office headed by chief medical officer Dr. Frank Maddux. Frenova offers services for […]
MassDevice Network
@MassDevice
LinkedIn
YouTube